A Study of CK-1827452 Infusion in Stable Heart Failure

Status:
Completed

Trial end date:
2009-02-01

Target enrollment:

Participant gender:

This study will assess the safety, tolerability, and pharmacodynamics of CK-1827452 infusion in patients with stable heart failure.

Phase 2

Cytokinetics